123 related articles for article (PubMed ID: 23607749)
1. Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients.
Shan SG; Gao YT; Xu YJ; Huang Y; Zhang Q; Zhai DK; Li JB; Wang FM; Jing X; Du Z; Wang YJ
Hepatol Res; 2013 Nov; 43(11):1199-210. PubMed ID: 23607749
[TBL] [Abstract][Full Text] [Related]
2. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.
Sun Y; Yang H; Mao Y; Xu H; Zhang J; Li G; Lu X; Sang X; Zhao H; Zhong S; Huang J; Zhang H
J Gastroenterol Hepatol; 2011 Jul; 26(7):1207-12. PubMed ID: 21443671
[TBL] [Abstract][Full Text] [Related]
3. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
4. Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.
Tian L; Wang Y; Xu D; Gui J; Jia X; Tong H; Wen X; Dong Z; Tian Y
Int J Cancer; 2011 Oct; 129(8):1923-31. PubMed ID: 21140449
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
Yu WM; Li GW; Lou MG; Wu ZY
BMC Gastroenterol; 2023 Nov; 23(1):401. PubMed ID: 37978447
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis.
Sai W; Wang L; Zheng W; Yang J; Pan L; Cai Y; Qiu L; Zhang H; Wu W; Yao D
Hepat Mon; 2015 Dec; 15(12):e32918. PubMed ID: 26977166
[TBL] [Abstract][Full Text] [Related]
7. Possible roles of Golgi protein-73 in liver diseases.
Liu MY; Huang L; Wu JF; Zhang HB; Ai WB; Zhang RT
Ann Hepatol; 2022; 27(5):100720. PubMed ID: 35577277
[TBL] [Abstract][Full Text] [Related]
8. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma.
Dong M; Chen ZH; Li X; Li XY; Wen JY; Lin Q; Ma XK; Wei L; Chen J; Ruan DY; Lin ZX; Wang TT; Wu DH; Wu XY
Oncol Lett; 2017 Nov; 14(5):6277-6284. PubMed ID: 29113278
[TBL] [Abstract][Full Text] [Related]
9. Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma.
Hu X; Yuan S; Zhou S; Sun T; Wang C; Ying S; Zhu H; Luo J; Jin H; Liu Y
Int J Biol Sci; 2023; 19(12):3694-3708. PubMed ID: 37564210
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of anti-GP73 monoclonal antibodies and development of double-antibody sandwich ELISA.
Li QW; Chen HB; Li ZY; Shen P; Qu LL; Gong LL; Xu HP; Pang L; Si J
Asian Pac J Cancer Prev; 2015; 16(5):2043-9. PubMed ID: 25773808
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
[TBL] [Abstract][Full Text] [Related]
12. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
13. High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.
Ai N; Liu W; Li ZG; Ji H; Li B; Yang G
Oncol Lett; 2017 Oct; 14(4):3953-3958. PubMed ID: 28943903
[TBL] [Abstract][Full Text] [Related]
14. Serum Golgi protein 73 is a prognostic biomarker of liver transplantation patients.
Wang Y; Zhang Z; Zou D; Hao Q; Ma X; Wang C; Zhang J; Zhang X; Wang B; Wang X; Yang X
Int J Clin Exp Pathol; 2017; 10(8):8626-8632. PubMed ID: 31966719
[TBL] [Abstract][Full Text] [Related]
15. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
16. Serum Golgi protein 73 as a sensitive biomarker for early detection of hepatocellular carcinoma among Egyptian patients with hepatitis C virus-related cirrhosis.
Eissa M; Awad S; Barakat S; Saleh A; Rozaik S
Med J Armed Forces India; 2021 Jul; 77(3):331-336. PubMed ID: 34305287
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
[TBL] [Abstract][Full Text] [Related]
19. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
[TBL] [Abstract][Full Text] [Related]
20. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
